EUVIMEDEUVIMED entdecken
Open Access · CC BY 2.0

Targeting TLR4/3 using chlorogenic acid ameliorates LPS+POLY I:C-induced acute respiratory distress syndrome via alleviating oxidative stress-mediated NLRP3/NF-κB axis

Siddhi Jain iD, Pritam Saha, Nayadi Parambil Syamprasad, Samir Rajan Panda, Bishal Rajdev, Arun Kumar Jannu, Pawan Sharma iD, Vegi Ganga Modi Naidu iD

Clinical Science · 2023

DOI: 10.1042/cs20220625 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, 2023. Verfasst von Siddhi Jain und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila village, Changsari, Guwahati, A…. Hauptthemen laut MEDLINE: NF-kappa B, Respiratory Distress Syndrome. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) is a life-threatening condition caused due to significant pulmonary and systemic inflammation. Chlorogenic acid (CGA) has been shown to possess potent antioxidant, anti-inflammatory, and immunoprotective properties. However, the protective effect of CGA on viral and bacterial-induced ALI/ARDS is not yet explored. Hence, the current study is aimed to evaluate the preclinical efficacy of CGA in lipopolysaccharide (LPS) and polyinosinic:polycytidylic acid (POLY I:C)-induced ALI/ARDS models in vitro and in vivo. Human airway epithelial (BEAS-2B) cells exposed to LPS+POLY I:C significantly elevated oxidative stress and inflammatory signaling. Co-treatment with CGA (10 and 50 µM) prevented inflammation and oxidative stress mediated by TLR4/TLR3 and NLRP3 inflammasome axis. BALB/c mice, when chronically challenged with LPS+POLY I:C showed a significant influx of immune cells, up-regulation of pro-inflammatory cytokines, namely: IL-6, IL-1β, and TNF-α, and treatment with intranasal CGA (1 and 5 mg/kg) normalized the elevated levels of immune cell infiltration as well as pro-inflammatory cytokines. D-Dimer, the serum marker for intravascular coagulation, was significantly increased in LPS+ POLY I:C challenged animals which was reduced with CGA treatment. Further, CGA treatment also has a beneficial effect on the lung and heart, as shown by improving lung physiological and cardiac functional parameters accompanied by the elevated antioxidant response and simultaneous reduction in tissue damage caused by LPS+POLY I:C co-infection. In summary, these comprehensive, in vitro and in vivo studies suggest that CGA may be a viable therapeutic option for bacterial and viral-induced ALI-ARDS-like pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BRespiratory Distress SyndromeMiceAnimalsHumansLipopolysaccharidesNLR Family, Pyrin Domain-Containing 3 ProteinChlorogenic AcidToll-Like Receptor 4AntioxidantsOxidative StressCytokinesInflammationPoly I

Stichwörter der Autor:innen

ARDSPOLYI:C and TLR3cardiac dysfunctionchlorogenic acidinflammationoxidative stress

Substanzen

NF-kappa BLipopolysaccharidesNLR Family, Pyrin Domain-Containing 3 ProteinChlorogenic AcidToll-Like Receptor 4AntioxidantsCytokinesPoly ITLR4 protein, humanNlrp3 protein, mouse

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila village, Changsari, Guwahati, Assam 781101, India.
  • Center for Translational Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Jane and Leonard Korman Respiratory Institute, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 1…
  • Department of Biotechnology, Centre for the Excellence of GMP Extraction Facility, National Institute of Pharmaceutical Education and Research Guwahati, Assam, India.

ORCID-Profile: Siddhi Jain, Pawan Sharma, Vegi Ganga Modi Naidu

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Jain, S., Saha, P., Syamprasad, N. P., Panda, S. R., Rajdev, B., Jannu, A. K., Sharma, P., & Naidu, V. G. M. (2023). Targeting TLR4/3 using chlorogenic acid ameliorates LPS+POLY I:C-induced acute respiratory distress syndrome via alleviating oxidative stress-mediated NLRP3/NF-κB axis. Clinical Science. https://doi.org/10.1042/cs20220625

Vancouver

Jain S, Saha P, Syamprasad NP, Panda SR, Rajdev B, Jannu AK, et al. Targeting TLR4/3 using chlorogenic acid ameliorates LPS+POLY I:C-induced acute respiratory distress syndrome via alleviating oxidative stress-mediated NLRP3/NF-κB axis. Clinical Science. 2023. doi:10.1042/cs20220625

BibTeX
@article{Jain2023,
  author = {Jain, Siddhi and Saha, Pritam and Syamprasad, Nayadi Parambil and Panda, Samir Rajan and Rajdev, Bishal and Jannu, Arun Kumar and Sharma, Pawan and Naidu, Vegi Ganga Modi},
  title = {Targeting TLR4/3 using chlorogenic acid ameliorates LPS+POLY I:C-induced acute respiratory distress syndrome via alleviating oxidative stress-mediated NLRP3/NF-κB axis},
  journal = {Clinical Science},
  year = {2023},
  doi = {10.1042/cs20220625}
}
Kostenlos starten →